quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:17·57d
INSIDERFiling
Twist Bioscience Corporation logo

Chief Financial Officer Laponis Adam sold $97,390 worth of shares (2,085 units at $46.71), decreasing direct ownership by 2% to 128,291 units (SEC Form 4)

TWST· Twist Bioscience Corporation
Health Care
Original source

Companies

  • TWST
    Twist Bioscience Corporation
    Health Care

Recent analyst ratings

  • Nov 4UpdateStephens$41.00
  • Dec 13UpdateWolfe Research$60.00
  • Jun 4UpdateGuggenheim$53.00
  • Jan 17UpdateGoldman$45.00
  • Sep 27UpdateBerenberg$27.00
  • Jan 5UpdateScotiabank$33.00

Related

  • INSIDER8h
    Chief Executive Officer Leproust Emily M. exercised 9,671 shares at a strike of $8.82 and sold $630,957 worth of shares (9,671 units at $65.24) as part of a pre-agreed trading plan (SEC Form 4)
  • INSIDER2d
    SEC Form 4 filed by Laponis Adam
  • PR2d
    Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
  • INSIDER7d
    SEC Form 4 filed by Laponis Adam
  • INSIDER10d
    SEC Form 4 filed by Laponis Adam
  • SEC14d
    SEC Form 144 filed by Twist Bioscience Corporation
  • INSIDER20d
    SEC Form 4 filed by Starovasnik Melissa A.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience Corporation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022